Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 4.3B | 4.0B | 3.6B |
Cost of revenue | 3.2B | 2.8B | 2.7B | 2.4B |
Gross profit | 1.6B | 1.5B | 1.4B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 575.2M | 515M | 492M | 444.3M |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 965.7M | 864.9M | 768.8M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 76.5M | 66.9M | 55.7M | 56.3M |
Other income expense | -29.4M | 11.5M | -34.2M | -48.7M |
Pretax income | 962.9M | 910.3M | 775M | 663.8M |
Tax provision | 218.7M | 158.3M | 166.1M | 135.1M |
Net income | 744.2M | 752M | 608.9M | 528.7M |
Basic EPS | 0.6 | 0.6 | 0.5 | 0.4 |
Diluted EPS | 0.6 | 0.6 | 0.5 | 0.4 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
EBITDA | 1.3B | 1.1B | 1.1B | 913.7M |
Net income from continuing op. | 744.2M | 752M | 608.8M | 528.8M |
Minority interests | -6.4M | -5.8M | -4.5M | -3.9M |
Preferred stock dividends | — | — | — | — |